LAUSSANE, Switzerland—The Obama administration is giving in to Iranian demands about the scope of its nuclear program as negotiators work to finalize a framework agreement in the coming days, according to sources familiar with the administration’s position in the negotiations.
U.S. negotiators are said to have given up ground on demands that Iran be forced to disclose the full range of its nuclear activities at the outset of a nuclear deal, a concession experts say would gut the verification the Obama administration has vowed would stand as the crux of a deal with Iran.
Until recently, the Obama administration had maintained that it would guarantee oversight on Tehran’s program well into the future, and that it would take the necessary steps to ensure that oversight would be effective. The issue has now emerged as a key sticking point in the talks.
Concern from sources familiar with U.S. concessions in the talks comes amid reports that Iran could be permitted to continue running nuclear centrifuges at an underground site once suspected of housing illicit activities.
This type of concession would allow Iran to continue work related to its nuclear weapons program, even under the eye of international inspectors. If Iran removes inspectors—as it has in the past—it would be left with a nuclear infrastructure immune from a strike by Western forces.
Obama revenge for Netanyahu's Congress talk? 1987 report on Israel's top secret nuclear program released in unprecedented move.
In a development that has largely been missed by mainstream media, the Pentagon early last month quietly declassified a Department of Defense top-secret document detailing Israel's nuclear program, a highly covert topic that Israel has never formally announced to avoid a regional nuclear arms race, and which the US until now has respected by remaining silent.
But by publishing the declassified document from 1987, the US reportedly breached the silent agreement to keep quiet on Israel's nuclear powers for the first time ever, detailing the nuclear program in great depth.
The timing of the revelation is highly suspect, given that it came as tensions spiraled out of control between Prime Minister Binyamin Netanyahu and US President Barack Obama ahead of Netanyahu's March 3 address in Congress, in which he warned against the dangers of Iran's nuclear program and how the deal being formed on that program leaves the Islamic regime with nuclear breakout capabilities.
Another highly suspicious aspect of the document is that while the Pentagon saw fit to declassify sections on Israel's sensitive nuclear program, it kept sections on Italy, France, West Germany and other NATO countries classified, with those sections blocked out in the document.
The 386-page report entitled "Critical Technological Assessment in Israel and NATO Nations" gives a detailed description of how Israel advanced its military technology and developed its nuclear infrastructure and research in the 1970s and 1980s.
Israel is "developing the kind of codes which will enable them to make hydrogen bombs. That is, codes which detail fission and fusion processes on a microscopic and macroscopic level," reveals the report, stating that in the 1980s Israelis were reaching the ability to create bombs considered a thousand times more powerful than atom bombs.
Why don't you buy their drugs and donate them to the poor?
A liver transplant costs far more than the Hep-C cure.
It's up to the Obamacare Death Panels to determine who gets cured.
U.S. Negotiations Give Iran Just Enough to Make the Bomb
Because of U.S. negotiations, Iran will reduce the number of its centrifuges whirling up useable radioactive material to 6,000 machines, according to the Associated Press. In turn, the U.S. would agree to ease sanctions. This is a bum deal for Secretary of State John Kerry if he wants to prevent Iran from getting the bomb. In February, former CIA Deputy Director Mike Morell said a safer negotiation route would have been to not focus on the number of centrifuges Iran possesses. "If you are going to have a nuclear weapons program, 5,000 is pretty much the number you need," Morell said. "If you have a power program, you need a lot more. By limiting them to a small number of centrifuges, we are limiting them to the number you need for a weapon." In other words, Kerry and Co. just stymied the ability for Iran to fuel its nuclear energy program, but left it just enough hardware to mix up a nuclear bomb. Let's hope all the details of this deal are not yet disclosed. Did Iran open itself up to monitoring and scrutiny? Or are they given a bunch of tools for nuclear enrichment and some space? The Associated Press continued, reporting that the vast majority of lawmakers in the House sent a letter to Barack Obama saying they will decide if the U.S. will ease sanctions against Iran. It's a good check on Obama's power.
This is big because it could drive oil prices even lower...
The United States and Iran are drafting elements of a nuclear deal that commits Tehran to a 40 percent cut in the number of machines it could use to make an atomic bomb, officials told The Associated Press on Thursday. In return, the Iranians would get quick relief from some crippling economic sanctions and a partial lift of a U.N. embargo on conventional arms.
Agreement on Iran's uranium enrichment program could signal a breakthrough for a larger deal aimed at containing the Islamic Republic's nuclear activities.
The sides are racing to meet a March 31 deadline for a framework pact and a full agreement by the end of June — even as the U.S. Congress keeps up pressure on the administration to avoid any agreement leaving Iran with an avenue to become a nuclear power.
Officials said the tentative deal imposes at least a decade of new limits on the number of centrifuges Iran can operate to enrich uranium, a process that can lead to nuclear weapons-grade material. The sides are zeroing in on a cap of 6,000 centrifuges, officials said, down from the 6,500 they spoke of in recent weeks.
That's also fewer than the 10,000 such machines Tehran now runs, yet substantially more than the 500 to 1,500 that Washington originally wanted as a ceiling. Only a year ago, U.S. officials floated 4,000 as a possible compromise.
But U.S. officials insist the focus on centrifuge numbers alone misses the point. Combined with other restrictions on enrichment levels and the types of centrifuges Iran can use, Washington believes it can extend the time Tehran would need to produce a nuclear weapon to at least a year.
Right now, Iran would require only two to three months to amass enough material to make a bomb.
The pressure in Congress on the administration over Iran remained intense, with the chairman of the Senate Foreign Relations Committee saying he wants to give lawmakers a say over any nuclear deal.
Stockpiles rose 9.6 million barrels, or 2.1 percent, to 458.5 million barrels last week, the EIA reported today. Analysts had expected an increase of 4.4 million barrels. The amount of oil the U.S. is cranking out also rose, for the sixth consecutive week, to a rate of 9.42 million barrels a day.
Oil investors have been glued to the levels of storage tanks, which have been climbing steadily since the oil-price crash started last year. American stockpiles are more than 25 percent above their five-year average. Inventories aren't likely to max out, but even the possibility of that happening is adding pressure to an oversupplied oil market.
U.S. inventories will probably continue to rise for the next few months, as refineries conduct seasonal maintenance and investors hold out for higher prices, according to Bloomberg Intelligence. In addition to traditional storage in tanks represented in today's numbers, drillers have left thousands of nearly finished wells untapped in what's become de facto storage, sometimes known as the fracklog. Prices are low, storage is filling up, and oil-drilling rigs are being idled at an unprecedented rate. But the U.S. oil boom hasn't slowed yet.
The entry of copycat biotech drugs into the U.S. market could cut prices of expensive medications by 40 percent to 50 percent, depending on the level of competition among drugmakers, a top executive at CVS Health told Reuters.
CVS is one of the largest U.S. pharmacy benefit managers and, along with rival Express Scripts, has put unprecedented pressure on global pharmaceutical makers to lower prices for its clients.
Iran’s foreign minister and chief negotiator in nuclear talks with the West declared victory for his country, stating that no matter how the negotiations end, Tehran has come out “the winner,” according to remarks made on Tuesday and presented in the country’s state-run press.
Javad Zarif, the Islamic Republic’s foreign minister, stated in remarks before the country’s powerful Assembly of Experts, which recently installed a hardline new cleric as its leader, that the nuclear negotiations have established Tehran as a global power broker.
“We are the winner whether the [nuclear] negotiations yield results or not,” Zarif was quoted as saying before the assembly by the Tasnim News Agency. “The capital we have obtained over the years is dignity and self-esteem, a capital that could not be retaken.”
Zarif’s comments were accompanied by a host of bold military displays by Tehran in recent weeks, including the announcement of one new weapon that Iranian military leaders have described as a “very special” missile.
As the United States and Iran rush to hash out a final nuclear agreement ahead of a self-imposed July deadline, Zarif also lashed out at congressional Republicans who have expressed skepticism over the Obama administration’s diplomacy and have fought to exert control over the implementation of any deal.
Zarif dismissed as a “propaganda ploy” a recent letter signed by 47 Senate Republicans that warned Tehran against placing too much stock in a weak deal agreed to by the Obama administration.
President Obama put several red lines for the Islamic Republic, but the ruling mullah breached the lines with no reaction from the White House. To save face, President Obama began making concessions and an unprecedented level of compromises.
At the first stage, President Obama and Secretary of State John Kerry allowed Iran to maintain the right to enrich uranium. Later, President Obama gave Iran the right to keep several hundred of its advanced centrifuges. The number later increased to a couple thousand, four thousand, and currently it is up to 6000.
In addition, President Obama made a concession to permit the Islamic Republic to maintain its heavy water plutonium reactor in Arak and continue constructing it soon.
Moreover, Obama and Kerry continued to make inaccurate statements to the public that Iran is “living up” to the requirements of the interim deal. According to the last week report from the IAEA, Iran still denies providing full access to information and its nuclear sites. Last week, the IAEA reported its concern, stating that the agency “remains concerned about the possible existence in Iran of undisclosed nuclear related activities involving military-related organizations, including activities related to the development of a nuclear payload for a missile.” The IAEA added that it cannot conclude that Iran’s nuclear activities are peaceful and that there are no “undeclared nuclear material and activities in Iran.”
There are other enrichment facilities. Check out Urenco and Louisiana Energy Services LES..
LEU has the best technology since GE cancelled he Silex plant.
In a recent report, analysts at JMP Securities expressed their bullish outlook for three stocks following meetings with company executives at the JMP Securities Technology Conference this week.
Here is a summary of what analysts had to say about the three names.
TubeMogul Inc (NASDAQ: TUBE)
Analysts have several major takeaways from their fireside chat with CFO Paul Joachim. According to Joachim, the company's future margin expansion will likely be driven by its transformation to Platform Direct, and investors can expect the company's investments in Programmatic TV and Display to rise in 2015.
Analysts believe that the recent 31 percent sell-off in TubeMogul shares is overdone.
"We continue to believe that TubeMogul is well-positioned to grow its share of the $70B+ domestic TV advertising market as advertisers increasingly follow audiences online, creating a positive risk/reward in the shares," they explain in the report.
JMP Securities has an Outperform rating on TubeMogul and a $21 target for the stock.
Shorting the stock into earnings was a great move, but now all the bad news is factored in and all the potential sellers have already sold.
The last short to cover may be doing so above $23 a share and given the current short percent of float, TUBE may see a short squeeze if they announce a big new contract.
Imagine if they get a buyout offer...
Columnist Dennis Prager: "Appeasers hate those who confront evil. Given that this president is the least likely of any president in American history to confront evil – or even identify it – while Benjamin Netanyahu is particularly vocal and eloquent about both identifying and confronting evil, it is inevitable that the former will resent the latter. ... [T]hose who refused to characterize the Soviet Union as evil loathed Ronald Reagan and other anti-communists for doing so; and those who objected to the 'Axis of Evil' label placed on North Korea, Iran, and Iraq loathed George W. Bush and his supporters. The loathing of Benjamin Netanyahu is simply the latest example of the rule that those who will not confront evil will instead confront those who do. (It’s much safer, after all.) "
Susan Rice told AIPAC It was ‘neither realistic nor achievable’ to expect Iran to stop enriching uranium:
‘We cannot let a totally unachievable ideal stand in the way of a good deal. I know that some of you will be urging Congress to insist that Iran forgo its domestic enrichment capacity entirely,’ Rice told AIPAC, as the crowd broke in to cheer.
‘But, but, but as desirable as that would be, it is neither realistic nor achievable.’
Didn't Obama list that as his number one foreign policy goal?
Late last week, Gilead Sciences, Inc. GILD announced detailed 48-week results from two phase III studies − Studies 104 and 111 − on an investigational once-daily single-tablet regimen containing tenofovir alafenamide (TAF). Both studies evaluated the TAF-containing tablets for the treatment of HIV-1 infection in treatment-naïve patients.
Based on these results, Gilead stated that its tenofovir alafenamide-containing investigational therapy was the first TAF-based regimen that was found to be non-inferior to Stribild and also enhanced in terms of renal and bone parameters. The company added that a TAF-based single-tablet regimen has the potential to address the needs of HIV patients undergoing life-long antiretroviral therapy.
Meanwhile, Gilead filed a new drug application for the E/C/F/TAF combination with the FDA in Nov 2014. An action from the agency is expected by Nov 2015. The combination therapy is also under review in the EU.
Typically, when stock falls hard there is a second wave of selling when people get home from work and check their portfolios. I bought more Friday and plan on using today to further reduce my cost basis.
Let's hope TUBE was simply giving conservative guidance.
No analyst has yet changed their rating on the stock, which is comforting.